HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 10, October 2019 – Disruptive Urban Farming — Microbes, Plasmids, and Recycling       » Chinese scientist find new possibilities in dengue virus control       » 50 young scientists awarded with the inaugural XPLORER PRIZE       » Entering the China market to provide regional support       » Science, Tech, and policies convene for a sustainable future      
EYE ON CHINA
Digital mental health strategy in China
Holmusk signs Memorandum of Understanding with Janssen (China) Research & Development Center to develop digital mental health strategy in China

Holmusk has signed a Memorandum of Understanding (MoU) with Janssen (China) Research & Development Center (Janssen), a Division of Johnson & Johnson (China) Investment Ltd., to explore the development of a digital mental health strategy in China.

The MoU brings together Janssen’s 60-plus years of experience developing treatments to improve mental health and its China neuroscience portfolio with Holmusk’s digital mental health platform and therapeutics design expertise to develop integrated solutions to help people living with depression and other mental health disorders.

More than 54 million people in China (4.2% of the population) suffer from depression. Proper diagnosis and treatment for depression is rare, especially in underserved regions, with less than 2 out of 10 patients seeking medical help or taking medications. Stigma regarding mental health remains high, preventing many patients from seeking care, and China has only 1.7 psychiatrists for every 100,000 people.

While depression costs China USD 7.8 billion a year in lost work days, medical expenses and funeral expenses, there is a lack of available, credible data on both prevalence and treatment.

Holmusk and Janssen propose to focus on generating insights from real-world data on depression and other mental health disorders to develop novel, scalable solutions to address the increasing burden of disease in the People’s Republic of China. The parties would also identify areas of unmet need that a digital platform can enhance, and define the supporting, prioritized functionality based on the Janssen Neuroscience portfolio in China. Holmusk’s digital therapeutics and deep analytics will be used to develop and implement a competitive, comprehensive solution for mental health in China, with an initial focus on depression.

Holmusk will work with Janssen to develop a strategy that applies Holmusk’s digital therapeutics capabilities and deep mental health analytics expertise to leverage big data and real-world evidence for a broad spectrum of mental health challenges. The combination of Holmusk’s mental health platform and Janssen’s expertise and network will be used to inform future, targeted management of wellness-oriented consumers, as well as mental health patients.

Source: Holmusk

Click here for the complete issue.

NEWS CRUNCH  
news The Proteona Oncology Challenge using ESCAPETM Single Cell Proteogenomic Analysis
news New computational fluid dynamics solution for modeling aerosol mixtures in biomedical and environmental research
news Medial Fair Thailand opened on 11th September 2019 with a focus on future-proofing Thailand's healthcare industry to meet the challenges and opportunities of the next decade
news Biofuel Producers and Users to Convene in Singapore for Global Biofuels Summit
PR NEWSWIRE  
Asia Pacific Biotech News
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
August:
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
September:
Healthy Ageing — How Science is chipping in
October:
Disruptive Urban Farming — Microbes, Plasmids, and Recycling
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy